intravascular brachytherapy

intravascular brachytherapy

Interventional cardiology The intracoronary administration of beta radiation to prevent restenosis of coronary arteries–which occurs in ±50% of Pts after balloon and other forms of angioplasty
References in periodicals archive ?
Intravascular brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group no.
In my 25 years of battling heart disease, I have undergone three open heart surgeries, intravascular brachytherapy and multiple bare metal stent procedures," said Rehak.
Calibration and characterization of [beta]-particle sources for intravascular brachytherapy.
This information package introduces the Checkmate[TM] Intravascular Brachytherapy System.
The first intravascular brachytherapy (radiation) system for recurrent blockages in coronary arteries previously treated with coronary artery stents is a vast improvement over existing technology, according to Paul Teirstein, director of interventional cardiology, Scripps Clinic, La Jolla, Calif.
This year we also completed a safety and feasibility trial of our TheraSource(R) Intravascular Brachytherapy System for the prevention of restenosis, or renarrowing, of leg arteries following treatment of peripheral vascular disease by balloon angioplasty.
A Scripps Institute randomized trial of intravascular brachytherapy with IVUS guidance of symmetrical radiation to prevent in-stent restenosis demonstrated a 68.
Our current internal diversification focus is on our TheraP trial, our patented peripheral intravascular brachytherapy device, which has now been implanted in 14 patients.
The study will test the safety and feasibility of the Company's TheraSource(TM) Intravascular Brachytherapy System designed to prevent restenosis, or renarrowing, of leg arteries following treatment of peripheral vascular disease by percutaneous transluminal angioplasty (PTA), also known as balloon angioplasty.
Additional exciting news for Theragenics(TM) is the commencement of human clinical trials to test the feasibility of the TheraSource(TM) Intravascular Brachytherapy System.
Additionally, this patent builds on our already broad intellectual property portfolio that includes patents for coronary catheters and angioplasty balloons, stents, drug delivery systems and intravascular brachytherapy," added Mr.
Food and Drug Administration (FDA) approval to market the CHECKMATE(TM) System, the first intravascular brachytherapy (radiation) system for recurrent blockages in coronary arteries previously treated with coronary artery stents, the tiny mesh braces used to prop open narrowed heart vessels.

Full browser ?